Chordia Therapeutics Inc.'s market cap is currently ¥8.03B. The company's EPS TTM is ¥-5.6; its P/E ratio is ―; Chordia Therapeutics Inc. is scheduled to report earnings on October 10, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Currency in JPY
Chordia Therapeutics Inc. Earnings and Revenue History
